AVB-401
Asset
Delivers a functional BAG3 gene to restore BAG3 expression in cardiac muscle.
- Stage
- Preclinical
- Modality
- Gene therapy
- Target
- BAG3
- 1
- Indication
- 0
- Trials
- 2
- Developers
Indications
1BAG3-mediated dilated cardiomyopathy
Preclinical, sec.gov, Dec 5, 2022
In the full profile
- Targets and what it contains1
- Owner and partners4
- Evidence for its targets1
Every asset’s record: target, stage, trials and the evidence behind it.